Monocyte-derived macrophage microparticles impart tissue factor activity to biomaterial surfaces

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 2, 2010, Pages 724-732

  Patchipulusu, Sirisha ^a   Turturro, Michael ^a   Hall, Connie L ^a  

^a Illinois Institute of Technology   (United States)

Author keywords

Biomaterials; Microparticles; Thrombosis; Tissue factor

Indexed keywords

BIOMATERIAL SURFACES; BOVINE SERUM ALBUMINS; CARDIOVASCULAR IMPLANTS; COATED GLASS; COATED SURFACE; FLOW CONDITION; FLOW STUDIES; MICRO-PARTICLES; MODEL SYSTEM; MONOCYTE-DERIVED MACROPHAGES; POLYDIMETHYLSILOXANE PDMS; SHEAR RATES; STATIC EXPERIMENTS; THROMBOGENICITY; THROMBOSIS; TISSUE FACTORS; WALL SHEAR RATES;

ADHESION; BIOMATERIALS; BODY FLUIDS; COAGULATION; GLASS; GRAFTS; MACROPHAGES; PLASMA DEPOSITION; PLASMAS; POLYSTYRENES; SHEAR DEFORMATION; SILICONES; SURFACES; SUSPENSIONS (FLUIDS); TISSUE; TISSUE CULTURE;

COATED MATERIALS;

BIOMATERIAL; BLOOD CLOTTING FACTOR 10A; BOVINE SERUM ALBUMIN; DACRON; DIMETICONE; POLYETHYLENE; POLYSTYRENE; THROMBOPLASTIN;

ARTICLE; CELL ADHESION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; SHEAR RATE; SURFACE PROPERTY; THROMBOGENICITY;

ANTIGENS; BIOCOMPATIBLE MATERIALS; CELL SEPARATION; FLOW CYTOMETRY; HUMANS; INDICATORS AND REAGENTS; MACROPHAGES; MONOCYTES; NANOPARTICLES; PARTICLE SIZE; SURFACE PROPERTIES; THROMBOPLASTIN;

EID: 75149189485     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32320     Document Type: Article

References (32)

1. Kappelmayer J, Bernabei A, Edmunds LH Jr, Edgington TS, Colman RW. Tissue factor is expressed on monocytes during simulated extracorporeal circulation. Circ Res 1993;72:1075-1081.
2. Palmerini T, Coller BS, Cervi V, Tomasi L, Marzocchi A, Marrozzini C, Leone O, Piccioli M, Branzi A. Monocyte-dervied tissue factor contributes to stent thrombosis in an in vitro system. J Am Coll Cardiol 2004;44:1570-1577.
3. Furie B, Furie BC. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 2004;10:171-178.
4. Berckmans RJ, Nieuwland R, Böing AN, Romjin FPHTM, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001;85:639-646.
5. Diamant M, Nieuwland R, Pablo R, Sturk A, Smit JWA, Radder JK. Elevated numbers of tissue factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002; 106:2442-2447.
6. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet J-M, Tedgui A. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000;101:841-843.
7. Yu JL, Rak JW. Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released from human cancer cells. J Thromb Haemost 2004;2:2065-2067.
8. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, Maquelin KN, Roozendaal K, Jansen PGM, ten Have K, Hack E, Sturk A. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997;96:3534-3541.
9. Philippou H, Adami A, Davidson SJ, Pepper JR, Burman JF, Lane DA. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass. Thromb Haemost 2000;84:124-128.
10. Brisset A-C, Terrisse A-D, Dupouy D, Tellier L, Pech S, Navarro C, Sié P. Shedding of active tissue factor by aortic smooth muscle cells (SMGs) undergoing apoptosis. Thromb Haemost 2003;90:511-518.
11. Freyssinet J-M, Toti F, Hugel B, Gidon-Jeangirard C, Kunzelmann C, Martinez MC, Meyer D. Apoptosis in vascular disease. Thromb Haemost 1999;82:727-735.
12. Leroyer A, Isobe H, Leseche G, Castier Y, Wassef M, Mallat Z, Binder BR, Tedgui A, Boulanger CM. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 2007;49:772-777.
13. Freyssinet J-M. Cellular microparticles: What are they bad or good for? J Thromb Haemost 2003;1:1655-1662.
14. Biro E, Sturk-Maquelin KN, Vogel GMT, Meuleman DG, Smit MJ, Hack CE. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J Thromb Haemost 2003;1:2561-2568.
15. Sturk-Maquelin KN, Nieuwland R, Romjin FPHTM, Eijsman CE, Hacks CE, Sturk A. Pro- and non-coagulant forms of non-cell-bound tissue factor in vivo. J Thromb Haemost 2003; 1:1920-1926.
16. Tans G, Rosing J, Christella M, Thomassen LGD, Heeb MJ, Zwaal RFA, Griffin JH. Comparison of anticoagulant an procoagulant activities of stimulated platelets and plateletderived microparticles. Blood 1991;77:2641-2648.
17. Steppich B, Mattisek C, Sobczyk D, Kastrati A, Schömig A, Ott I. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction. Thromb Haemost 2005;93:35-39.
18. Vandendries ER, Furie BC, Furie B. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thromb Haemost 2004; 92:459-466.
19. Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000;96:170-175.
20. Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries ER, Celi A, Croce K, Furie BC, Furie B. Accumulation of tissue factor into the developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selection. J Exp Med 2003;11:1585-1598.
21. Hanson SR, Harker LA. Blood coagulation and blood-materials interactions. In: Ratner BD, Hoffman AS, Schoen FJ, editors. Biomaterials Science. San Diego: Academic Press, 1996. p 193-199.
22. Raybagkar DA, Patchipulusu S, Mast AE, Hall CL. In vitro flow evaluation of recombinant tissue factor pathway inhibitor immobilized on collagen-impregnated Dacron. ASAIO J 2004;50:301-305.
23. Altieri DC, Edgington TS. The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor. J Biol Chem 1988;263:7007-7015.
24. Plescia J, Altieri DC. Activation of Mac-1 (CD11b/CD18)-bound factor X by released cathepsin G defines an alternative pathway of leucocyte initiation of coagulation. Biochem J 1996;319:873-879.
25. Furie B, Furie BC. Cancer-associated thrombosis. Blood Cells Mol Dis 2006;36:177-181.
26. Shet AS, Aras O, Gupta K, Hass MJ, Rausch DJ, Saba N, Koopmeiners L, Key NS, Hebbel RP. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003;102:2678-2683.
27. del Conde I, Shrimpton CN, Thiagarajan P, López JA. Tissuefactor-bearing microsvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005;106:1604-1611.
28. Wolf Z, Orsó E, Werner T, Boettcher A, Schmitz G. A flow cytometric screening test for detergent-resistant surface antigens in monocytes. Cytometry A 2006;69A:192-195.
29. Anderson JA, Miller KM. Biomaterial biocompatibility and the macrophage. Biomaterials 1984;5:5-10.
30. 2. Mac-1) integrin and promotes leukocyte adhesion. J Biol Chem 1993;268:1847-1853.
31. Turitto VT, Hall CL. Mechanical factors affecting hemostasis and thrombosis. Thromb Res 1998;92:S25-S31.
32. Okorie UM, Denney WS, Chatterjee MS, Neeves KB, Diamond SL. Determination of surface tissue factor thresholds that trigger coagulation at venous and arterial shear rates: Amplification of 100 fM circulating tissue factor requires flow. Blood 2008;111:3507-3513.